Plant-based vaccine for environmental remediation and contamination prevention

Publication ID: 24-11857613_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Plant-based vaccine for environmental remediation and contamination prevention,” Published Technical Disclosure No. 24-11857613_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857613_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,613.

Summary of the Inventive Concept

A novel application of the original vaccine technology to prevent Clostridium perfringens growth in various environmental settings, including soil, water, agricultural facilities, food production, and the built environment.

Background and Problem Solved

The original patent focused on protecting poultry from C. perfringens infection. However, C. perfringens is a ubiquitous organism that can contaminate various environments, leading to significant ecological and economic impacts. The new inventive concept addresses this limitation by applying the core vaccine technology to prevent C. perfringens growth in diverse settings.

Detailed Description of the Inventive Concept

The new inventive concept involves the development of plant-based vaccines for environmental remediation and contamination prevention. These vaccines would be administered to soil-dwelling organisms, introduced into polluted water sources, applied to agricultural settings, used to prevent contamination in food production facilities, and incorporated into HVAC systems in the built environment. The vaccines would reduce C. perfringens populations and associated toxins, mitigating environmental and health risks.

Novelty and Inventive Step

The new claims introduce a novel application of the original vaccine technology, shifting the focus from poultry protection to environmental remediation and contamination prevention. This inventive step lies in the recognition of the vaccine's potential to address a broader range of C. perfringens-related problems, beyond the original context.

Alternative Embodiments and Variations

Alternative embodiments could include different plant-based vaccine delivery systems, such as nanoparticles or microorganisms, or the use of various plant species for vaccine production. Variations could also involve the development of vaccines targeting other Clostridium species or strains.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including environmental remediation, agriculture, food production, and facility management. The market for environmental remediation alone is projected to grow significantly in the coming years, driven by increasing concerns about ecological sustainability and public health.

CPC Classifications

SectionClassGroup
A A61 A61K39/08
A A61 A61P31/04
C C12 C12N15/74
C C12 C12N15/8258
A A61 A61K2039/552
A A61 A61K2039/55577

Original Patent Information

Patent NumberUS 11,857,613
TitleVaccine for prevention of necrotic enteritis in poultry
Assignee(s)Arizona Board of Regents on Behalf of Arizona State University